ATF6-Mediated Signaling Contributes to PARP Inhibitor Resistance in Ovarian Cancer
Journal Article
Overview
publication date
- January 1, 2023
has subject area
- Adnexal Diseases - Ovarian Neoplasms
- Antineoplastic Agents
- Antineoplastic Agents - Poly(ADP-ribose) Polymerase Inhibitors
- Cell Line - Cell Line, Tumor
- DNA-Binding Proteins - Activating Transcription Factor 6
- DNA-Binding Proteins - Transcription Factor AP-1
- Drug Resistance, Neoplasm
- Endocrine System Diseases - Ovarian Neoplasms
- Enzyme Inhibitors - Poly(ADP-ribose) Polymerase Inhibitors
- Female
- Female Urogenital Diseases - Ovarian Neoplasms
- Gonadal Disorders - Ovarian Neoplasms
- Humans
- Neoplasms by Site - Ovarian Neoplasms
- Peptides - Activating Transcription Factor 6
- Proteins - Activating Transcription Factor 6
- Transcription Factors - Activating Transcription Factor 6
- Transcription Factors - Transcription Factor AP-1
- Tumor Cells, Cultured - Cell Line, Tumor
has restriction
- bronze
Date in CU Experts
- January 28, 2023 9:28 AM
Full Author List
- McMellen A; Yamamoto TM; Qamar L; Sanders BE; Nguyen LL; Chavez DO; Bapat J; Berning A; Post MD; Johnson J
author count
- 14
citation count
- 4
published in
- Molecular Cancer Research Journal
Other Profiles
International Standard Serial Number (ISSN)
- 1541-7786
Electronic International Standard Serial Number (EISSN)
- 1557-3125
Digital Object Identifier (DOI)
Additional Document Info
start page
- 3
end page
- 13
volume
- 21
issue
- 1